Jornal Vascular Brasileiro
https://app.periodikos.com.br/journal/jvb/article/doi/10.1590/1677-5449.202401601
Jornal Vascular Brasileiro
Original Article

Tratamento ambulatorial de varizes com endolaser em clínica × hospital: avaliação de custo-benefício e segurança

Outpatient treatment of varicose veins with endolaser in clinic vs. hospital: cost-benefit and safety assessment

Camila Biedler Giordani; Mateus Picada Correa; Luiza Brum Borges; Vitória Cerbaro Farias; Renan Camargo Puton; Jaber Nashat Saleh; Rafael Stevan Noel; Julio Cesar Bajerski

Downloads: 0
Views: 9

Resumo

Contexto: A doença varicosa é comum entre a população, com incidência de cerca de 38%. No Brasil, ela atinge 45% das mulheres e 30% dos homens. Atualmente, a termoablação endovenosa (TAEV) de safenas é o método de escolha no tratamento de varizes. Por ser um procedimento minimamente invasivo, que promove rápida recuperação e não exige internação hospitalar, ele pode ser realizado a nível ambulatorial.

Objetivos: Avaliar a segurança e o custo-benefício do tratamento ambulatorial de varizes em clínica, comparando ao mesmo procedimento realizado em ambiente hospitalar.

Métodos: Estudo transversal, retrospectivo e não controlado, do tipo série de casos, que avaliou um grupo aleatório de 50 pacientes submetidos à TAEV para tratamento de doença varicosa, realizado por um mesmo grupo de cirurgiões vasculares. Entre os pacientes, 25 realizaram o tratamento em hospital terciário e 25 ambulatorialmente. As médias dos custos de taxa de sala e de materiais dos dois grupos foram analisadas e comparadas estatisticamente com o teste t de Student. Complicações intra e pós-operatórias foram avaliadas.

Resultados: A média do custo hospitalar do procedimento foi de R$ 1.391,99 (± 280,8) no hospital e de R$ 1.593,40 (± 99,53) na clínica. O teste t de Student apresentou diferença significativa, com p = 0,02. Nenhum paciente teve complicações intra ou pós-operatórias.

Conclusões: A cirurgia ambulatorial, apesar de ter um custo estatisticamente maior que a hospitalar no Brasil, é segura e tem custo-benefício positivo para o paciente.

Palavras-chave

cirurgia ambulatorial; termoablação endovenosa; varizes; custo-benefício

Abstract

Background: Varicose disease is a common pathology among the population, with an incidence of about 38%. In Brazil, it affects 45% of women and 30% of men. Currently, endovenous thermal ablation (EVTA) of the saphenous vein is the method of choice in the treatment of varicose veins. As a minimally invasive procedure that promotes quick recovery and does not require hospitalization, it can be performed on an outpatient basis

Objectives: To evaluate the safety and cost-benefit of outpatient varicose vein treatment in a clinic compared to the same procedure performed in a hospital environment.

Methods: A uncontrolled retrospective transversal study of case series evaluated a random group of 50 patients undergoing EVTA for the treatment of varicose disease by the same group of vascular surgeons. Twenty-five underwent the procedure in a tertiary hospital environment and 25 on an outpatient basis. The average costs of room fees and materials from both groups were analyzed and statistically compared with the Student’s t-test. Intraoperative and postoperative complications were assessed

Results: The average hospital cost of the procedure was R$ 1391.99 (± 280.8) in the hospital and R$ 1593.40 (± 99.53) in the clinic. The Student’s t-test showed a significant difference with p=0.02. No patient had complications either intraoperatively or postoperatively

Conclusions: Outpatient surgery, despite having a statistically higher cost than hospital surgery in Brazil, is safe and has a positive cost-benefit for the patient.

Keywords

outpatient surgery; endovenous thermal ablation; varicose veins; cost-benefit

References

1 Chung JH, Heo S. Varicose veins and the diagnosis of chronic venous disease in the lower extremities. J Chest Surg. 2024;57(2):109-19. http://doi.org/10.5090/jcs.23.110. PMid:37994090.

2 Gawas M, Bains A, Janghu S, Kamat P, Chawla P. A comprehensive review on varicose veins: preventive measures and different treatments. J Am Nutr Assoc. 2022;41(5):499-510. http://doi.org/10.1080/07315724.2021.1909510. PMid:34242131.

3 Raetz J, Wilson M, Collins K. Varicose veins: diagnosis and treatment. Am Fam Physician. 2019;99(11):682-8. PMid:31150188.

4 Sociedade Brasileira de Angiologia e de Cirurgia Vascular. Estimativas [Internet]. 2024 [citado 2024 abr 25]. https://sbacv.org.br/imprensa/estimativas/

5 De Maeseneer MG, Kakkos SK, Aherne T, et al. European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184-267. http://doi.org/10.1016/j.ejvs.2021.12.024. PMid:35027279.

6 Varetto G, Gibello L, Frola E, et al. Day surgery versus outpatient setting for endovenous laser ablation treatment: a prospective cohort study. Int J Surg. 2018;51:180-3. http://doi.org/10.1016/j.ijsu.2018.01.039. PMid:29412185.

7 Darwood RJ, Theivacumar N, Dellagrammaticas D, Mavor AI, Gough MJ. Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg. 2008;95(3):294-301. http://doi.org/10.1002/bjs.6101. PMid:18278775.

8 Deindl C, Neumann A. The future of outpatient surgery. Urologie. 2022;61(8):829-38. http://doi.org/10.1007/s00120-022-01878-5. PMid:35925293.

9 Bellani ML. Psychological aspects in day-case surgery. Int J Surg. 2008;6(Supl Suppl 1):S44-6. http://doi.org/10.1016/j.ijsu.2008.12.019. PMid:19167936.

10 Keo HH, Spinedi L, Staub D, et al. Safety and efficacy of outpatient endovenous laser ablation in patients 75 years and older: a propensity score-matched analysis. Swiss Med Wkly. 2019;149:w20083. http://doi.org/10.4414/smw.2019.20083. PMid:31154658.

11 Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health. 2022;25(1):3-9. http://doi.org/10.1016/j.jval.2021.11.1351. PMid:35031096.

12 Galanopoulos G, Lambidis C. Minimally invasive treatment of varicose veins: endovenous laser ablation (EVLA). Int J Surg. 2012;10(3):134-9. http://doi.org/10.1016/j.ijsu.2012.02.013. PMid:22373866.

13 Kikuchi R, Nhuch C, Drummond DAB, et al. Brazilian guidelines on chronic venous disease of the Brazilian Society of Angiology and Vascular Surgery. J Vasc Bras. 2023;22:e20230064. http://doi.org/10.1590/1677-5449.202300642. PMid:38021274.

14 Sewonou A, Rioux C, Golliot F, et al. Incidence of surgical site infection in ambulatory surgery: results of the INCISCO surveillance network in 1999-2000. Ann Chir. 2002;127(4):262-7. http://doi.org/10.1016/S0003-3944(02)00741-1. PMid:11980298.

15 Owens PL, Barrett ML, Raetzman S, Maggard-Gibbons M, Steiner CA. Surgical site infections following ambulatory surgery procedures. JAMA. 2014;311(7):709-16. http://doi.org/10.1001/jama.2014.4. PMid:24549551.

16 Guillaumon AT, Rocha EF. Análise de custos de safenectomia ambulatorial em hospital universitário. Rev Col Bras Cir. 2004;31(3):183-6. http://doi.org/10.1590/S0100-69912004000300007.

17 Miola AC, Espósito ACC, Miot HA. Técnicas de randomização e alocação para estudos clínicos. J Vasc Bras. 2024;23:e20240046. PMid:39866165.


Submitted date:
12/12/2024

Accepted date:
04/21/2025

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
685e9d53a9539532b9646ee5 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections